SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001274644-17-000030
Filing Date
2017-04-25
Accepted
2017-04-25 16:44:33
Documents
4
Period of Report
2017-06-20
Effectiveness Date
2017-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A oceraproxydocumentsecversi.htm DEF 14A 733487
2 newoceralogoa09.jpg GRAPHIC 11170
3 newoceralogoa10.jpg GRAPHIC 11170
4 oceralogoa14.jpg GRAPHIC 14112
  Complete submission text file 0001274644-17-000030.txt   779607
Mailing Address 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301 6504750158
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35119 | Film No.: 17781600
SIC: 2834 Pharmaceutical Preparations